Sanofi

News

Sanofi appoints former Novartis exec Hudson as CEO

Sanofi has appointed Novartis’ pharma chief Paul Hudson as chief executive to replace the retiring Olivier Brandicourt, prompting a reshuffle for its Swiss rival.

News

Sanofi names ex-Roche cancer guru Dietmar Berger as developm...

Roche alumnus Dietmar Berger has joined Sanofi as head of development following a short stint in biotech.

News

Lilly moves Crohn's drug into phase 3, faces safety setback ...

Eli Lilly has had a mixed few days, posting promising trial results for mid-stage Crohn’s disease drug mirikizumab, undercutting a key insulin from Sanofi in the US, but facing safety conce

Events

GIC Pharma Social - Speaker Horizontal-01 (3) 29.04

Partner Content

The Pharma Social Media Conference

Pharma Social Media

News

Sanofi claims EU okay for Dupixent in asthma

Sanofi and partner Regeneron have picked up an approval in Europe for Dupixent in asthma, unlocking an important new indication for the fast-growing biologic.

News

Cholesterol drug from Sanofi/Regeneron gains US CV risk redu...

Sanofi and Regeneron’s Praluent cholesterol drug has been approved in the US to help prevent cardiovascular events, a new indication that will help it compete with Amgen’s rival from the sa

Sanofi appoints former Novartis exec Hudson as CEO

Sanofi names ex-Roche cancer guru Dietmar Berger as developm...

Lilly moves Crohn's drug into phase 3, faces safety setback ...

The Pharma Social Media Conference

Sanofi claims EU okay for Dupixent in asthma

Cholesterol drug from Sanofi/Regeneron gains US CV risk redu...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Sanofi

Editor's Picks